These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
557 related articles for article (PubMed ID: 23565830)
1. Incidence of invasive fungal disease after unmanipulated haploidentical stem cell transplantation was significantly higher than that after HLA-matched sibling transplantation. Sun Y; Xu L; Liu D; Zhang X; Han W; Wang Y; Chen H; Chen Y; Wang F; Wang J; Ji Y; Tang F; Liu K; Huang XJ Clin Microbiol Infect; 2013 Nov; 19(11):1029-34. PubMed ID: 23565830 [TBL] [Abstract][Full Text] [Related]
2. Epidemiology, management, and outcome of invasive fungal disease in patients undergoing hematopoietic stem cell transplantation in China: a multicenter prospective observational study. Sun Y; Meng F; Han M; Zhang X; Yu L; Huang H; Wu D; Ren H; Wang C; Shen Z; Ji Y; Huang X Biol Blood Marrow Transplant; 2015 Jun; 21(6):1117-26. PubMed ID: 25840339 [TBL] [Abstract][Full Text] [Related]
3. Risk factors for invasive fungal disease after allogeneic hematopoietic stem cell transplantation: a single center experience. Omer AK; Ziakas PD; Anagnostou T; Coughlin E; Kourkoumpetis T; McAfee SL; Dey BR; Attar E; Chen YB; Spitzer TR; Mylonakis E; Ballen KK Biol Blood Marrow Transplant; 2013 Aug; 19(8):1190-6. PubMed ID: 23747459 [TBL] [Abstract][Full Text] [Related]
4. HLA-haploidentical blood and bone marrow transplantation with anti-thymocyte globulin: long-term comparison with HLA-identical sibling transplantation. Chen XH; Gao L; Zhang X; Gao L; Zhang C; Kong PY; Liu H; Peng XG; Sun AH; Qi DG; Gong Y; Wang QY Blood Cells Mol Dis; 2009; 43(1):98-104. PubMed ID: 19356956 [TBL] [Abstract][Full Text] [Related]
5. Role of antithymocyte globulin and granulocyte-colony stimulating factor-mobilized bone marrow in allogeneic transplantation for patients with hematologic malignancies. Chen XH; Zhang C; Zhang X; Gao L; Gao L; Kong PY; Peng XG; Qi DG; Sun AH; Zeng DF; Liu H; Gong Y; Wang QY Biol Blood Marrow Transplant; 2009 Feb; 15(2):266-73. PubMed ID: 19167687 [TBL] [Abstract][Full Text] [Related]
6. HLA-mismatched/haploidentical hematopoietic stem cell transplantation without in vitro T cell depletion for chronic myeloid leukemia: improved outcomes in patients in accelerated phase and blast crisis phase. Xiao-Jun H; Lan-Ping X; Kai-Yan L; Dai-Hong L; Huan C; Wei H; Yu-Hong C; Jing-Zhi W; Yao C; Xiao-Hui Z; Hong-Xia S; Dao-Pei L Ann Med; 2008; 40(6):444-55. PubMed ID: 18608121 [TBL] [Abstract][Full Text] [Related]
7. Incidence and outcome of invasive fungal diseases after allogeneic stem cell transplantation: a prospective study of the Gruppo Italiano Trapianto Midollo Osseo (GITMO). Girmenia C; Raiola AM; Piciocchi A; Algarotti A; Stanzani M; Cudillo L; Pecoraro C; Guidi S; Iori AP; Montante B; Chiusolo P; Lanino E; Carella AM; Zucchetti E; Bruno B; Irrera G; Patriarca F; Baronciani D; Musso M; Prete A; Risitano AM; Russo D; Mordini N; Pastore D; Vacca A; Onida F; Falcioni S; Pisapia G; Milone G; Vallisa D; Olivieri A; Bonini A; Castagnola E; Sica S; Majolino I; Bosi A; Busca A; Arcese W; Bandini G; Bacigalupo A; Rambaldi A; Locasciulli A Biol Blood Marrow Transplant; 2014 Jun; 20(6):872-80. PubMed ID: 24631738 [TBL] [Abstract][Full Text] [Related]
8. The incidence and risk factors of invasive fungal infection after haploidentical haematopoietic stem cell transplantation without in vitro T-cell depletion. Sun YQ; Xu LP; Liu DH; Zhang XH; Chen YH; Chen H; Ji Y; Wang Y; Han W; Wang JZ; Wang FR; Liu KY; Huang XJ Clin Microbiol Infect; 2012 Oct; 18(10):997-1003. PubMed ID: 22085092 [TBL] [Abstract][Full Text] [Related]
9. Treatment of acute leukemia with unmanipulated HLA-mismatched/haploidentical blood and bone marrow transplantation. Huang XJ; Liu DH; Liu KY; Xu LP; Chen H; Han W; Chen YH; Zhang XH; Lu DP Biol Blood Marrow Transplant; 2009 Feb; 15(2):257-65. PubMed ID: 19167686 [TBL] [Abstract][Full Text] [Related]
10. Modified donor lymphocyte infusion-associated acute graft-versus-host disease after haploidentical T-cell-replete hematopoietic stem cell transplantation: incidence and risk factors. Yan CH; Liu DH; Xu LP; Liu KY; Zhao T; Wang Y; Chen H; Chen YH; Han W; Huang XJ Clin Transplant; 2012; 26(6):868-76. PubMed ID: 22432715 [TBL] [Abstract][Full Text] [Related]
11. Favorable outcome of haploidentical hematopoietic stem cell transplantation in Philadelphia chromosome-positive acute lymphoblastic leukemia: a multicenter study in Southwest China. Gao L; Zhang C; Gao L; Liu Y; Su Y; Wang S; Li B; Yang T; Yuan Z; Zhang X J Hematol Oncol; 2015 Jul; 8():90. PubMed ID: 26208715 [TBL] [Abstract][Full Text] [Related]
12. Role of acute graft-versus-host disease in the risk of bacteremia and invasive fungal disease after allogeneic hemopoietic stem cell transplantation in children. Results from a single-center observational study. Castagnola E; Bagnasco F; Bandettini R; Caviglia I; Morreale G; Lanino E; Giardino S; Moroni C; Haupt R; Faraci M Biol Blood Marrow Transplant; 2014 Jul; 20(7):1068-73. PubMed ID: 24691219 [TBL] [Abstract][Full Text] [Related]
13. Related HLA-mismatched/haploidentical hematopoietic stem cell transplantation without in vitro T-cell depletion: observations of a single Chinese center. Huang X; Liu D Clin Transpl; 2011; ():237-45. PubMed ID: 22755417 [TBL] [Abstract][Full Text] [Related]
14. G-CSF given after haematopoietic stem cell transplantation using HLA-identical sibling donors is associated to a higher incidence of acute GVHD II-IV. Remberger M; Naseh N; Aschan J; Barkholt L; LeBlanc K; Svennberg P; Ringdén O Bone Marrow Transplant; 2003 Jul; 32(2):217-23. PubMed ID: 12838288 [TBL] [Abstract][Full Text] [Related]
15. Unmanipulated HLA-mismatched/haploidentical peripheral blood stem cell transplantation for high-risk hematologic malignancies. Huang W; Li H; Gao C; Bo J; Wang Q; Zhao Y; Jing Y; Wang S; Zhu H; Dou L; Wang L; Yu L Transfusion; 2012 Jun; 52(6):1354-62. PubMed ID: 22233440 [TBL] [Abstract][Full Text] [Related]
16. [The clinical characteristic and risk factors for the incidence of invasive fungal infection in patients following allogeneic hematopoietic stem cell transplantation]. Zhang Y; Liu C; Liu QF; Sun J; Fan ZP; Xu D; Jiang QL Zhonghua Yi Xue Za Zhi; 2009 Nov; 89(40):2814-7. PubMed ID: 20137659 [TBL] [Abstract][Full Text] [Related]
17. Indications and outcomes of antifungal therapy in French patients with haematological conditions or recipients of haematopoietic stem cell transplantation. Herbrecht R; Caillot D; Cordonnier C; Auvrignon A; Thiébaut A; Brethon B; Michallet M; Mahlaoui N; Bertrand Y; Preziosi P; Ruiz F; Gorin NC; Gangneux JP J Antimicrob Chemother; 2012 Nov; 67(11):2731-8. PubMed ID: 22850692 [TBL] [Abstract][Full Text] [Related]
18. Incidence and characteristics of invasive fungal diseases in allogeneic hematopoietic stem cell transplant recipients: a retrospective cohort study. Harrison N; Mitterbauer M; Tobudic S; Kalhs P; Rabitsch W; Greinix H; Burgmann H; Willinger B; Presterl E; Forstner C BMC Infect Dis; 2015 Dec; 15():584. PubMed ID: 26715563 [TBL] [Abstract][Full Text] [Related]
19. Outcome of haematopoietic stem cell transplantation in patients transplanted with matched unrelated donors vs allele-mismatched donors: a single centre study. Hauzenberger D; Schaffer M; Ringdén O; Hassan Z; Omazic B; Mattsson J; Wikström AC; Remberger M Tissue Antigens; 2008 Dec; 72(6):549-58. PubMed ID: 19000143 [TBL] [Abstract][Full Text] [Related]
20. Low incidence of severe acute graft-versus-host disease in children given haematopoietic stem cell transplantation from unrelated donors prospectively matched for HLA class I and II alleles with high-resolution molecular typing. Giebel S; Giorgiani G; Martinetti M; Zecca M; Maccario R; Salvaneschi L; Holowiecki J; Locatelli F Bone Marrow Transplant; 2003 Jun; 31(11):987-93. PubMed ID: 12774049 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]